Last update July 1, 2015
Compatible
We do not have alternatives for リファキシミン since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
リファキシミン is Rifaximin in Japanese.
Is written in other languages:リファキシミン is also known as
リファキシミン belongs to this group or family:
Main tradenames from several countries containing リファキシミン in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | < 0.4 | % |
Molecular weight | 786 | daltons |
Protein Binding | 68 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Antibiótico derivado de la rifamicina, no aborbible, utilizado por vía oral para tratar determinadas diarreas y afecciones intestinales.
A fecha de última actualización no encontramos datos publicados en relación con la lactancia pero su falta casi absoluta de absorción intestinal (< 1%) y su elevado peso molecular hacen muy improbable su paso a leche. Por otra parte sus posibles efectos secundarios son leves y casi limitados a molestias abdominales.